Aptevo Therapeutics Inc. Receivables, Long-term Contracts or Programs
Aptevo Therapeutics Inc. (APVO) had Receivables, Long-term Contracts or Programs of $3.11 million as of 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesLongTermContractsOrPrograms · last filed 2022-11-10
- 2022-03-31: Receivables, Long-term Contracts or Programs $3.11M.
- 2021-12-31: Receivables, Long-term Contracts or Programs $3.66M.
- 2021-09-30: Receivables, Long-term Contracts or Programs $3.10M.
- 2021-06-30: Receivables, Long-term Contracts or Programs $3.11M.
| Period end | Receivables, Long-term Contracts or Programs |
|---|---|
| 2022-03-31 | $3.11M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.66M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $3.10M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $3.11M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.42M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.37M 10-K · filed 2022-03-24 |
| 2020-09-30 | $1.46M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $288.00K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |